EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-nephrin autoantibodies in podocytopathies: pathogenicity, assay discordance, and translation

Peidong Feng, Xiaoyong Yu

Frontiers in Immunology · 2026

DOI: 10.3389/fimmu.2026.2000932 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Peidong Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. Hauptthemen laut MEDLINE: Autoantibodies, Membrane Proteins, Podocytes, Glomerulosclerosis, Focal Segmental. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Experimental targeting of nephrin causes proteinuria and podocyte injury, and human studies identify anti-nephrin autoantibodies in a subset of podocytopathies. Serum and tissue recognition, associations with disease activity, and transfer of patient total immunoglobulin G support an autoimmune endotype. The pathogenic contribution of the naturally occurring nephrin-specific fraction has not been fully resolved. This narrative review examines target recognition, pathogenic effects, clinical validity, and the benefit of acting on a test result as separate questions. We focus on adult minimal change disease and primary focal segmental glomerulosclerosis, with childhood nephrotic syndrome and transplant recurrence providing complementary evidence. Experimental studies explain how nephrin targeting alters slit diaphragm organization and signaling. Comparisons of original studies identify glycan and tag interference, platform-dependent detection, and differences in treatment exposure and antibody class. Low detection with human-cell antigens also supports considering genuine variation in the frequency of this endotype. Observational studies show serologic changes with disease activity and signals preceding relapse or transplant recurrence. These findings motivate investigational applications in disease characterization, monitoring, and risk assessment. Assays remain unstandardized, and autoantibody-guided management has not been shown to improve outcomes over standard care. Prospective studies and decision-focused trials should determine when these signals add useful information and improve treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesMembrane ProteinsPodocytesGlomerulosclerosis, Focal SegmentalHumansAnimals

Stichwörter der Autor:innen

autoantibodyfocal segmental glomerulosclerosisimmunoassayminimal change diseasenephrinnephrotic syndrome

Substanzen

AutoantibodiesMembrane Proteinsnephrin

Autor:innen und Institutionen

  • Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
  • Department of Nephrology, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, China.

Zitieren

APA

Feng, P., & Yu, X. (2026). Anti-nephrin autoantibodies in podocytopathies: pathogenicity, assay discordance, and translation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.2000932

Vancouver

Feng P, Yu X. Anti-nephrin autoantibodies in podocytopathies: pathogenicity, assay discordance, and translation. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.2000932

BibTeX
@article{Feng2026,
  author = {Feng, Peidong and Yu, Xiaoyong},
  title = {Anti-nephrin autoantibodies in podocytopathies: pathogenicity, assay discordance, and translation},
  journal = {Frontiers in Immunology},
  year = {2026},
  doi = {10.3389/fimmu.2026.2000932}
}
Kostenlos starten →